110 related articles for article (PubMed ID: 9329515)
1. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics.
Tan S; Hall IP; Dewar J; Dow E; Lipworth B
Lancet; 1997 Oct; 350(9083):995-9. PubMed ID: 9329515
[TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroid treatment modulates ZNF432 gene variant's effect on bronchodilator response in asthmatics.
Wu AC; Himes BE; Lasky-Su J; Litonjua A; Peters SP; Lima J; Kubo M; Tamari M; Nakamura Y; Qiu W; Weiss ST; Tantisira K
J Allergy Clin Immunol; 2014 Mar; 133(3):723-8.e3. PubMed ID: 24280104
[TBL] [Abstract][Full Text] [Related]
3. ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the Atherosclerosis Risk in Communities study.
Ferdinands JM; Mannino DM; Gwinn ML; Bray MS
PLoS One; 2007 Mar; 2(3):e289. PubMed ID: 17356698
[TBL] [Abstract][Full Text] [Related]
4. A genome-wide association study of bronchodilator response in asthmatics.
Duan QL; Lasky-Su J; Himes BE; Qiu W; Litonjua AA; Damask A; Lazarus R; Klanderman B; Irvin CG; Peters SP; Hanrahan JP; Lima JJ; Martinez FD; Mauger D; Chinchilli VM; Soto-Quiros M; Avila L; Celedón JC; Lange C; Weiss ST; Tantisira KG
Pharmacogenomics J; 2014 Feb; 14(1):41-7. PubMed ID: 23508266
[TBL] [Abstract][Full Text] [Related]
5. Discriminating measures of bronchodilator drug efficacy and potency.
Buck H; Parry-Billings M
Br J Clin Pharmacol; 2001 Sep; 52(3):245-53. PubMed ID: 11560556
[No Abstract] [Full Text] [Related]
6. Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation.
King C; McKenna A; Farzan N; Vijverberg SJ; van der Schee MP; Maitland-van der Zee AH; Arianto L; Bisgaard H; BØnnelykke K; Berce V; PotoČnik U; Repnik K; Carleton B; Daley D; Chew FT; Chiang WC; Sio YY; Cloutier MM; Den Dekker HT; Duijts L; de Jongste JC; Dijk FN; Flores C; Hernandez-Pacheco N; Mukhopadhyay S; Basu K; Tantisira KG; Verhamme KM; Celedón JC; Forno E; Canino G; Francis B; Pirmohamed M; Sinha I; Hawcutt DB
Pharmacogenomics J; 2020 Oct; 20(5):621-628. PubMed ID: 31949291
[TBL] [Abstract][Full Text] [Related]
7. Chinese expert consensus on diagnosis and management of severe asthma.
Lin J; Yang D; Huang M; Zhang Y; Chen P; Cai S; Liu C; Wu C; Yin K; Wang C; Zhou X; Su N
J Thorac Dis; 2018 Dec; 10(12):7020-7044. PubMed ID: 30746249
[No Abstract] [Full Text] [Related]
8. Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets.
Mishra V; Banga J; Silveyra P
Pharmacol Ther; 2018 Jan; 181():169-182. PubMed ID: 28842273
[TBL] [Abstract][Full Text] [Related]
9. Heat Shock-Related Protein 20 Peptide Decreases Human Airway Constriction Downstream of β2-Adrenergic Receptor.
Banathy A; Cheung-Flynn J; Goleniewska K; Boyd KL; Newcomb DC; Peebles RS; Komalavilas P
Am J Respir Cell Mol Biol; 2016 Aug; 55(2):225-33. PubMed ID: 26909644
[TBL] [Abstract][Full Text] [Related]
10. Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics.
Bandaru S; Akka J; Marri VK; Alvala M; Ponnala D; Mundluru HP
Inflammation; 2015 Dec; 38(6):2146-55. PubMed ID: 26071206
[TBL] [Abstract][Full Text] [Related]
11. Beta2 adrenergic receptor (ADRβ2) haplotype pair (2/4) is associated with severe asthma.
Chung LP; Baltic S; Ferreira M; Temple S; Waterer G; Thompson PJ
PLoS One; 2014; 9(4):e93695. PubMed ID: 24691493
[TBL] [Abstract][Full Text] [Related]
12. Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors.
de Paiva AC; Marson FA; Ribeiro JD; Bertuzzo CS
Allergy Asthma Clin Immunol; 2014 Feb; 10(1):8. PubMed ID: 24499171
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of polymorphism of adrenergic Beta-2 receptor and mild asthma: a clinical and pharmacogenetic study.
Adimi Naghan P; Fahimi F; Nadji SA; Naderi N; Soleimani F; Masjedi MR
Iran J Pharm Res; 2013; 12(1):199-204. PubMed ID: 24250589
[TBL] [Abstract][Full Text] [Related]
14. Obesity and asthma.
Baruwa P; Sarmah KR
Lung India; 2013 Jan; 30(1):38-46. PubMed ID: 23661915
[TBL] [Abstract][Full Text] [Related]
15. Personalised medicine and asthma diagnostics/management.
Wadsworth SJ; Sandford AJ
Curr Allergy Asthma Rep; 2013 Feb; 13(1):118-29. PubMed ID: 23212666
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the benefits of suplatast tosilate, a Th2 cytokine inhibitor, and gene polymorphisms in children with bronchial asthma.
Matsui E; Shinoda S; Fukutomi O; Kaneko H; Fukao T; Kondo N
Exp Ther Med; 2010 Nov; 1(6):977-982. PubMed ID: 22993628
[TBL] [Abstract][Full Text] [Related]
17. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.
Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
Cochrane Database Syst Rev; 2010 May; (5):CD005535. PubMed ID: 20464739
[TBL] [Abstract][Full Text] [Related]
18. beta(2)-adrenergic receptor promoter haplotype influences spirometric response during an acute asthma exacerbation.
Moore PE; Williams SM; Gebretsadik T; Jiang L; Minton PL; Shintani A; Phillips Iii JA; Dawson EP; Hartert TV
Clin Transl Sci; 2008 Sep; 1(2):155-61. PubMed ID: 20443840
[TBL] [Abstract][Full Text] [Related]
19. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.
Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
Cochrane Database Syst Rev; 2010 Apr; (4):CD005533. PubMed ID: 20393943
[TBL] [Abstract][Full Text] [Related]
20. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.
Ni Chroinin M; Greenstone I; Lasserson TJ; Ducharme FM
Cochrane Database Syst Rev; 2009 Oct; (4):CD005307. PubMed ID: 19821344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
